Literature DB >> 30251479

Diuretics and left ventricular hypertrophy regression: The relationship that we commonly forget.

Marijana Tadic1, Cesare Cuspidi2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30251479      PMCID： PMC8031262          DOI： 10.1111/jch.13381

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  17 in total

1.  Effect of spironolactone on diastolic function in hypertensive left ventricular hypertrophy.

Authors:  A Gupta; C G Schiros; K K Gaddam; I Aban; T S Denney; S G Lloyd; S Oparil; L J Dell'Italia; D A Calhoun; H Gupta
Journal:  J Hum Hypertens       Date:  2014-09-18       Impact factor: 3.012

2.  Greater regression of electrocardiographic left ventricular hypertrophy during hydrochlorothiazide therapy in hypertensive patients.

Authors:  Peter M Okin; Darcy A Hille; Sverre E Kjeldsen; Lars H Lindholm; Jonathan M Edelman; Björn Dahlöf; Richard B Devereux
Journal:  Am J Hypertens       Date:  2010-04-15       Impact factor: 2.689

3.  Regression of Electrocardiographic Signs of Left Ventricular Hypertrophy by Combined Treatment With Thiazide Diuretic and Angiotensin-II Receptor Blocker.

Authors:  Takuma Sawa; Yukihito Sato; Mitsuo Matsuda; Masaru Tanaka; Shunichi Miyazaki; Yutaka Furukawa; Yoshio Kita; Yoshiki Takatsu; Hisayoshi Fujiwara
Journal:  Circ J       Date:  2014-09-30       Impact factor: 2.993

Review 4.  Head-to-head comparisons of hydrochlorothiazide with indapamide and chlorthalidone: antihypertensive and metabolic effects.

Authors:  George C Roush; Michael E Ernst; John B Kostis; Suraj Tandon; Domenic A Sica
Journal:  Hypertension       Date:  2015-03-02       Impact factor: 10.190

5.  Low-dose eplerenone decreases left ventricular mass in treatment-resistant hypertension.

Authors:  Andreas Schneider; Johannes Schwab; Marina V Karg; Tatjana Kalizki; Annemarie Reinold; Markus P Schneider; Roland E Schmieder; Bernhard M W Schmidt
Journal:  J Hypertens       Date:  2017-05       Impact factor: 4.844

6.  A randomized study of the beneficial effects of aldosterone antagonism on LV function, structure, and fibrosis markers in metabolic syndrome.

Authors:  Wojciech Kosmala; Monika Przewlocka-Kosmala; Hanna Szczepanik-Osadnik; Andrzej Mysiak; Trisha O'Moore-Sullivan; Thomas H Marwick
Journal:  JACC Cardiovasc Imaging       Date:  2011-12

7.  Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial).

Authors:  Elsayed Z Soliman; Walter T Ambrosius; William C Cushman; Zhu-Ming Zhang; Jeffrey T Bates; Javier A Neyra; Thaddeus Y Carson; Leonardo Tamariz; Lama Ghazi; Monique E Cho; Brian P Shapiro; Jiang He; Lawrence J Fine; Cora E Lewis
Journal:  Circulation       Date:  2017-05-16       Impact factor: 29.690

8.  Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study.

Authors:  Bertram Pitt; Nathaniel Reichek; Roland Willenbrock; Faiez Zannad; Robert A Phillips; Barbara Roniker; Jay Kleiman; Scott Krause; Daniel Burns; Gordon H Williams
Journal:  Circulation       Date:  2003-09-29       Impact factor: 29.690

9.  Electrocardiographic Left Ventricular Hypertrophy Predicts Cardiovascular Morbidity and Mortality in Hypertensive Patients: The ALLHAT Study.

Authors:  Casper N Bang; Elsayed Z Soliman; Lara M Simpson; Barry R Davis; Richard B Devereux; Peter M Okin
Journal:  Am J Hypertens       Date:  2017-09-01       Impact factor: 2.689

10.  Hydrochlorothiazide vs chlorthalidone, indapamide, and potassium-sparing/hydrochlorothiazide diuretics for reducing left ventricular hypertrophy: A systematic review and meta-analysis.

Authors:  George C Roush; Ramy Abdelfattah; Steven Song; Michael E Ernst; Domenic A Sica; John B Kostis
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-09-24       Impact factor: 3.738
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.